Effector Property Plant And Equipment Net from 2010 to 2025
| EFTR Stock | USD 0.0002 0.00 0.00% |
Property Plant And Equipment Net | First Reported 2010-12-31 | Previous Quarter 173.7 K | Current Value 280.2 K | Quarterly Volatility 300.1 K |
Check Effector Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Effector Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 104.8 K, Interest Expense of 2.1 M or Selling General Administrative of 10.1 M, as well as many indicators such as Price To Sales Ratio of 4.24, Dividend Yield of 0.0 or Days Sales Outstanding of 3.03. Effector financial statements analysis is a perfect complement when working with Effector Therapeutics Valuation or Volatility modules.
Effector | Property Plant And Equipment Net | Build AI portfolio with Effector Stock |
Additional Tools for Effector Stock Analysis
When running Effector Therapeutics' price analysis, check to measure Effector Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Effector Therapeutics is operating at the current time. Most of Effector Therapeutics' value examination focuses on studying past and present price action to predict the probability of Effector Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Effector Therapeutics' price. Additionally, you may evaluate how the addition of Effector Therapeutics to your portfolios can decrease your overall portfolio volatility.